SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001485003-22-000053
Filing Date
2022-05-03
Accepted
2022-05-03 08:00:21
Documents
16
Period of Report
2022-05-03
Items
Item 2.02: Results of Operations and Financial Condition
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K sesn-20220503.htm   iXBRL 8-K 44467
2 EX-99.1 a20220503strategicaltern.htm EX-99.1 12298
6 a20220503strategicaltern001.jpg GRAPHIC 290666
7 a20220503strategicaltern002.jpg GRAPHIC 309202
8 a20220503strategicaltern003.jpg GRAPHIC 292285
  Complete submission text file 0001485003-22-000053.txt   1433873

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT sesn-20220503.xsd EX-101.SCH 1914
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT sesn-20220503_lab.xml EX-101.LAB 24993
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT sesn-20220503_pre.xml EX-101.PRE 13190
10 EXTRACTED XBRL INSTANCE DOCUMENT sesn-20220503_htm.xml XML 11816
Mailing Address 245 FIRST STREET SUITE 1800 CAMBRIDGE MA 02142
Business Address 245 FIRST STREET SUITE 1800 CAMBRIDGE MA 02142 617-444-8550
Sesen Bio, Inc. (Filer) CIK: 0001485003 (see all company filings)

IRS No.: 262025616 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36296 | Film No.: 22884662
SIC: 2834 Pharmaceutical Preparations